Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award
Associate Professor Khoon Lim is a biomedical engineer specializing in polymer chemistry and biomaterials, affiliated with the School of Medical Sciences at the University of Sydney. He holds a PhD in Biomedical Engineering from UNSW Sydney and has conducted postdoctoral research at the University of Otago. His research focuses on hydrogels for tissue engineering, 3D bioprinting, and regenerative medicine, with over $8M in grant funding. Lim leads the Light Activated Biomaterials (LAB) research group and is a member of prestigious organizations like the Australasian Society for Biomaterials and Tissue Engineering. Education: BE (Chemical Engineering, Hons 1) and ME (Biomedical Engineering) from UNSW Sydney, followed by a PhD in Biomedical Engineering (2014). Postdoctoral fellowship at University of Otago Christchurch (2019). Research Interests: Biofabrication, 3D bioprinting, hydrogels for tissue regeneration, cardiovascular applications, and chronic disease management. Current projects include developing bioinks for functional tissues, smart delivery systems for growth factors, and cancer models for drug screening. Key Achievements: ARC Future Fellow (2022), Rutherford Discovery Fellowship (2021), and over 170 publications in journals like Advanced Materials and Biofabrication . Holds patents in hydrogel technologies. Leadership Roles: President of ASBTE, Board Member of ISBF, and editorial board positions in journals such as RSC Biomaterials Science . Active in translational research through collaborations in Australia, New Zealand, Europe, and Asia.
Johan Ulrik Lind is an Associate Professor and Groupleader at the Department of Health Technology, Technical University of Denmark. His research focuses on cutting-edge biomedical engineering solutions including tissue engineering, bioprinting, and microphysiological systems. He actively contributes to additive manufacturing and functional materials development. Current Affiliation: Department of Health Technology, DTU Research Areas: 3D bioprinting, hydrogel technologies, microsystems engineering Expertise: UN Sustainable Development Goals for health and well-being Lind's work spans additive manufacturing for tissue engineering, functionalized biomaterials , and dynamic microphysiological systems . His recent publications highlight innovations in hydrogel formulation, bioink development, and particulate drug delivery systems. Notably, he holds a patent for transparent bioink formulation. He supervises multiple PhD projects including: micro-perfused bioartificial ovaries, embedded bioprinting of perfusable vasculatures, and 3D printed microsystems for tissue actuation. His research portfolio demonstrates strong interdisciplinary collaboration across engineering, biology, and pharmaceutical sciences.
Prof. Dr. Leonid Ionov is a leading academic at the Faculty of Engineering Science , University of Bayreuth, specializing in Biofabrication and 4D Printing . He has held professorial roles since 2017, with prior positions at the University of Georgia and TU Dresden. Research Priorities: Smart responsive polymers, 3D/4D bioprinting, self-healing electronics, and bioinspired surface engineering. Teaching: Offers advanced courses in 3D Printing of Polymers , Biofabrication , and Polymer Science . His work integrates stimuli-responsive materials with additive manufacturing to create bioinspired actuators, vascular scaffolds, and self-healing conductive systems. Recent articles focus on 4D-printed vascular junctions , multi-responsive cellulose composites , and dynamic bilayer morphing . Scientific Achievements Recipient of the 2022 North Bavaria Business Plan Competition award 2012 Georg Manecke Prize for biopolymer research Developed European patents for Li-S battery cathodes and microfluidic devices Trained over 20 PhD/postdoc alumni now at institutions like Iowa State University and Harvard Medical School . Leads a multidisciplinary lab with advanced equipment for polymer synthesis, electrospinning, and cell culture studies.
Dr. Amir K. Miri is an Assistant Professor in the Department of Biomedical Engineering at New Jersey Institute of Technology (NJIT) and Director of the Advanced Biofabrication Lab. His work focuses on additive manufacturing for biomedical applications, particularly bioprinting technologies for tissue regeneration and disease modeling. After receiving his PhD in Mechanical Engineering from McGill University (2013) and completing postdoctoral training at the MIT-Harvard Division of Health Sciences and Technology, he began his academic career at Rowan University before joining NJIT. PhD, Mechanical Engineering, McGill University (2013) MSc, Mechanical Engineering, Sharif University of Technology (2007) BSc, Mechanical Engineering, Iran University of Science and Technology (2005) Dr. Miri's research spans advanced bioprinting platforms, including multi-axial extrusion, handheld printers, and digital light projection systems. His work emphasizes the development of biomimetic models for cancer, vocal fold tissue, and vascular systems, with a particular focus on microfluidic integration and material optimization for bioprinting. He has pioneered low-cost prototyping solutions for resource-limited settings and explored the role of extracellular matrix mechanics in cellular behavior. Key trends in his publications include 3D bioprinting for tumor modeling, microfluidic device applications in drug screening, and the use of hydrogels like GelMA in cancer research. His group has also advanced acoustic metasurface technology for biomedical wave manipulation and investigated the interplay between biomaterial rheology and bioprinting resolution. Dr. Miri leads a research team at NJIT focused on biofabrication and microfluidics, though specific student advisees are not listed in the provided information. His lab emphasizes interdisciplinary collaboration, particularly in the development of multi-material and multi-scale tissue constructs.
Dr Sanjeev Gambhir is a Senior Research Fellow at the Intelligent Polymer Research Institute, University of Wollongong. With over 30 years of experience in chemistry, he leads bioinks synthesis and scale-up activities at TRICEP (Translational Research Initiative for Cellular Engineering and Printing) facility. His work bridges academic research with commercial translation, particularly in 3D bioprinting of living tissues. B.Sc. and M.Sc. in Organic Chemistry from Garhwal University Ph.D. in Organic Chemistry from Indian Institute of Petroleum Research focuses on 3D bioprinting technologies, graphene composites, conducting polymers, and hydrogel engineering. Key challenges addressed include biomaterial diversity limitations, bioprinted construct characterisation, and scalable bioink formulation. His work spans tissue engineering, regenerative medicine, and industrial applications. Major publications appear in Nature Communications , Journal of the American Chemical Society , and Advanced Materials . With 60+ peer-reviewed papers and an H-index of 28, his research on graphene composites and conducting hydrogels has significant citations in biomedical and materials science domains. Frater Award (Australian National Fabrication Facility, 2013) Active in mentoring junior staff and students, Gambhir collaborates with Inventia Life Science Pty Ltd and Professor Fiona Wood at the University of Western Australia. Current funding includes MRFF grants for intraoperative skin regeneration systems and translational projects through University of Wollongong infrastructure grants.
Frederico Castelo Ferreira is an Associate Professor in the Department of Bioengineering at the Instituto Superior Técnico, University of Lisbon. His primary affiliation is with the Institute for Bioengineering and Biosciences (IST/IBB). He holds a dual focus on academic research and industrial collaboration, with expertise in bioengineering, bioprocess development, and biomaterials. Education: Ph.D. in Chemical Engineering (Imperial College London), postdoctoral training at Imperial College London and Universidade Nova de Lisboa, and MIT-Portugal Program involvement. Research: Specializes in sustainable biofuels, advanced separations in pharmaceuticals, and biomaterials for tissue engineering. Key projects include membrane-based systems for biofuel production, stem cell microenvironment engineering, and electroconductive scaffolds for neural and bone regeneration. Awards: 1st Prize for Knowledge Valorization (2008), Technology Venture Fellowship (2006). Activities: Founded the Portuguese Young Chemists Group, organized the 1st Portuguese Young Chemists Meeting (2007), and contributed to initiatives like CoHiTec 2008-2013. He has authored over 100 peer-reviewed publications, with a focus on biomaterials, bioprocesses, and tissue engineering. Teaching: Teaches courses in Bioentrepreneurship, Bioengineering Topics, and Advanced Biomaterials at the graduate level.
Devid Maniglio is an Associate Professor at the Department of Industrial Engineering, University of Trento. His research focuses on bioengineering, biomaterials, and tissue engineering, with a particular emphasis on bioprinting, surface modification, and functional materials. He has contributed to advancements in silk fibroin and hydrogel-based systems for medical applications. Research Interests Bioengineering for personalized medicine Biomaterials and surface engineering 3D bioprinting and tissue regeneration Molecular imprinting and biosensors Drug delivery and cell encapsulation Teaching Diagnostic and therapeutic technologies for personalized medicine Engineered materials for precision medicine Fundamentals of biomedical technologies Functional surfaces laboratory Labs & Collaborations Devid Maniglio is affiliated with the Functional Surfaces Laboratory at the University of Trento, collaborating with researchers such as Stefano Rossi and Flavio Deflorian. His work integrates interdisciplinary approaches in biomedical engineering and sustainable medical technologies.
Daniel Aili is a Professor and Head of Unit at Linköping University, affiliated with the Department of Physics, Chemistry and Biology within the Faculty of Science and Engineering. His research focuses on the design and development of functional nanoscale materials for biomedical applications, particularly through molecular self-assembly processes. PhD in Molecular Physics, Linköping University (2008) MSc in Engineering Biology, Linköping University (2003) Postdoctoral training at Nanyang Technological University, Singapore (2010–2011) Postdoc in Prof. Molly Stevens' lab, Imperial College London, UK (2009–2010) His research interests lie at the intersection of soft materials, nanotechnology, and biomedicine. He specializes in creating bioresponsive and biointeractive materials using self-assembly techniques. His work spans biosensors, drug delivery systems, regenerative medicine, and wound healing technologies. A key focus is on hydrogels and bioinks that mimic the extracellular matrix, enabling 3D and 4D bioprinting of tissue-like structures. Recent publications highlight advancements in nanocellulose-based wound dressings with infection-sensing capabilities, controlled antimicrobial release, and high-density biofabrication for skin regeneration. These studies reflect a strong trend toward translational biomaterials that bridge fundamental science with clinical applications, particularly in diagnostics and regenerative therapies. Daniel Aili has received numerous scientific honors, including: ERC Consolidator Grant Wallenberg Academy Fellow (with prolongation) Future Research Leader by the Swedish Foundation for Strategic Research AkzoNobel Nordic Prize for Surface and Colloid Chemistry (2012) Ingvar Carlsson Award (2012) Arnbergska Prize from the Royal Swedish Academy of Sciences (2013) He leads the Laboratory of Molecular Materials and has secured major grants from the Knut and Alice Wallenberg Foundation, the Swedish Foundation for Strategic Research (SSF), and the European Commission (Horizon 2020). He mentors several PhD students and contributes to large collaborative projects such as the SSF MED-X initiative HEALiX. His lab develops innovative materials that can grow artificial tissues, test cancer drugs, and create smart wound dressings that detect infection—contributing significantly to reducing animal testing and advancing personalized medicine. Daniel Aili’s research group operates within the interdisciplinary research environment Advanced Functional Materials (AFM) at Linköping University. The team combines expertise in biophysics, bioengineering, polymer chemistry, and materials science to push the boundaries of biomimetic material design. Their work on dynamic hydrogels and modular bioinks enables real-time control over cell behavior and tissue formation, positioning them at the forefront of next-generation regenerative therapies.
Sepidar Sayyar is a Research Fellow and materials scientist at the Australian National Fabrication Facility-Materials Node at the University of Wollongong, where he has been actively involved in research since 2014. He works at the Innovation Campus, AIIM Facility in Wollongong, Australia, focusing on advanced materials development and characterization. Dr. Sayyar earned his PhD in Materials Engineering from the University of Wollongong between 2011 and 2015. His academic journey has been centered at this institution, where he has developed expertise in composite materials, 3D printing technologies, and nanomaterials for biomedical applications. His research interests span multiple cutting-edge areas including Materials Engineering, Nanoscale Characterisation, Composite and Hybrid Materials, Nanobiotechnology, Nanotechnology, and Functional Materials. Dr. Sayyar's work particularly emphasizes the development and characterization of composite materials for various applications, with a strong focus on biomedical implementations. Analysis of his recent publications reveals a consistent research trajectory focused on 3D printing technologies for advanced materials, particularly in biomedical contexts. His work spans graphene applications, hydrogel development, and novel fabrication techniques for medical devices and electronics. The publications demonstrate interdisciplinary collaboration across materials science, biomedical engineering, and electronics. Dr. Sayyar actively supervises research students and has successfully guided multiple PhD and Master's candidates to completion. His supervision portfolio includes projects on cellulose composites, biocompatible conductive inks, degradable stents, flexible electrodes, and graphene-based fibers for health applications. He has been involved in several research funding projects including '3D Printed Conductive Flexible Strain Sensors for Skin-Interface Electronics' (2022-2023), 'Global Challenges: Next Generation Sustainable Crafting' (2019), 'Slow Textiles' (2019), and 'Material Science, Slow Textiles, and Ecological Futures' (2017-2019), demonstrating his diverse research interests and ability to secure funding across different domains. Working within the Intelligent Polymer Research Institute environment at the University of Wollongong, Dr. Sayyar collaborates with multidisciplinary teams focused on advanced materials development, contributing to the institute's reputation for innovation in polymer science and engineering applications.
Dr. Ilyas Khan is an Associate Professor in Biomedical Sciences at Swansea University's Medical School. His research focuses on regenerative medicine and tissue engineering, particularly in developing cartilage repair solutions for joint diseases like osteoarthritis. He leads a lab investigating stem cells' role in cartilage development, 3D tissue engineering, and translational clinical applications with NHS collaboration. Dr. Khan holds a PhD from Imperial College London (1996–2000) and has secured significant grants, including a £1.3M project (2014–2020) with Utrecht University. He teaches modules on regenerative medicine and supervises postgraduate students in areas like BMP9-induced cartilage maturation and synthetic bone allografts. His work bridges basic science and clinical translation, emphasizing global research impact. Teaching includes undergraduate courses on regenerative medicine and advanced nanomedicine modules. Collaborations span European and global institutions. Key research themes include stem cell biology, cartilage progenitor cells, and bioprinting. Scientific output includes over 20 peer-reviewed articles, with recent focus on BMP9 signaling and 3D scaffold technologies.
Abdellah Ajji is a Full Professor in the Department of Chemical Engineering at Polytechnique Montréal and holds the NSERC Prolamina Industrial Research Chair on Safe, Smart and Sustainable Packaging (3SPack). He directs the Flexible Polymer Packaging Laboratory (PolyFlexPack) and is a member of the Institute of Biomedical Engineering and the Center for High-Performance Polymer and Composite Systems (CREPEC). Rheology and processing of polymers Biomedical materials and tissue engineering Polymer properties and characterization Smart and sustainable packaging solutions His recent publications focus on 3D bioprinting , electrospun nanofibers , and polymer recycling across biomedical, food packaging, and renewable energy applications. Current research includes multifunctional films with antibacterial properties and photocrosslinkable bioinks for cardiac regeneration. Scientific awards include over $1M in CFI funding (2015) and recognition as one of the top 2% most cited researchers globally (2021). He supervises 6 postdoctoral researchers, 6 doctoral students, and 1 master’s student, with 32 completed PhDs and 23 completed master’s theses since 2006.
Assoc. Professor Zhilian Yue is a Principal Fellow at the Intelligent Polymer Research Institute , part of the Australian Institute for Innovative Materials at the University of Wollongong . With appointments since 2023 and prior roles as a Senior Research Fellow (2021), Yue specializes in advanced biomaterials and tissue engineering technologies. Education: B.Sc. (Polymer Chemistry, Hebei University), M.Sc. (Polymer Chemistry, Peking University), Ph.D. (Heriot-Watt University) Research Interests: Functional biomaterials, tissue engineering, regenerative medicine, nanomedicine, and electroactive hydrogels Yue's research focuses on 3D bioprinting, electrofluidic systems, and conducting polymer hydrogels for wireless electrostimulation, with recent articles emphasizing collagen-based bioinks, corneal regeneration, and vascularized constructs for diabetes therapy. His work spans collaborations on ARC Discovery Projects and Medical Research Future Fund initiatives, including grants for skin wound treatments and bipolar electroactive architectures. Supervision: Yue actively supervises Ph.D. projects on electroactive hydrogels, neural repair, and flexible sensors, while past supervisees have completed work on collagen scaffolds, islet transplantation, and conductive inks. Labs & Teams: Affiliated with the Intelligent Polymer Research Institute and Australian Institute for Innovative Materials
Dr. Amy Gelmi is a Senior Lecturer at RMIT University’s School of Science, specializing in biomedical engineering and nanotechnology. Her research focuses on advanced biomaterials, neural interfaces, and stem cell therapies for tissue regeneration. RMIT University, School of Science Senior Lecturer Research in biomedical engineering, nanotechnology, and analytical chemistry Coordinator for Chemistry for Food and Life Sciences courses Her research integrates multimodal approaches to engineer bioactive scaffolds, including 3D-printed thermoresponsive polymers , laser-patterned diamond electrodes , and bioelectronic platforms for neural and cardiac tissue engineering. Key themes include mechanotransduction, electrochemical stimulation, and epigenetic regulation in stem cell differentiation. A notable trend in her publications involves stimuli-responsive biomaterials that enable precise control over cellular behavior through physical cues like microgroove topography, high-frequency nanomechanostimulation, and conductive substrates. These works emphasize applications in tissue repair, stem cell programming, and bioelectronic devices. Teaching roles include coordination of Chemistry for Food and Life Sciences and Science Honours Research Methods . Collaborative projects span biofabrication, quantum sensing with nanodiamonds, and advanced hydrogel systems for regenerative medicine.
Dr. Anita Quigley is an Associate Professor in the School of Engineering at RMIT University. Her research focuses on regenerative medicine, biomaterials, and tissue engineering, with applications in neural interfaces, bioinks, and stem cell therapies. She leads a team exploring advanced materials for medical devices and has supervised 12 research-based projects since 2019. Her work spans interdisciplinary collaborations in biomedicine, nanotechnology, and engineering. Key research interests include developing bioengineered scaffolds for tissue repair, optimizing hydrogel properties for cell behavior, and studying neurological disorders using cerebral organoids. She contributes to committees like ACMD TRACE and maintains a strong publication record in biomaterials and biomedical engineering journals. Recent articles highlight innovations in melt-electrospun scaffolds, graphene-enhanced nerve regeneration systems, and optogenetic stimulation techniques. Her research bridges fundamental science and clinical applications, aiming to advance regenerative therapies and biomedical technologies.
